These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 4789497)

  • 1. [Clinical and therapeutic considerations on the use of a benzodiazepine derivative, bromazepam (Ro 5-3350) in the treatment of obsessive-phobic disorders].
    Salmoni G; Amati A; Giambelluca A; Vacca L
    Acta Neurol (Napoli); 1973; 28(5):588-609. PubMed ID: 4789497
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical trial of a new derivative of the series of benzodiazepines: bromazepam (Ro 5-3350) in the treatment of phobic-obsessive symptoms].
    Grattarola FR; Morgando E
    Minerva Med; 1973 May; 64(40):2107-11. PubMed ID: 4578170
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical evaluation of Bromazepam with special reference to obsessive syndromes and phobias].
    De Giacomo P; Pierri G
    Acta Neurol (Napoli); 1974; 29(3):307-13. PubMed ID: 4153901
    [No Abstract]   [Full Text] [Related]  

  • 4. [Polygraphic studies of nocturnal sleep of subjects with phobic-obsessive neuroses treated with a new benzodiazepine (RO 5-3350)].
    Di Perri R; Meduri M
    Riv Neurol; 1972; 42(6):512-9. PubMed ID: 4348761
    [No Abstract]   [Full Text] [Related]  

  • 5. [Anxiety and its emotional sedation].
    Pelicier Y
    Therapeutique; 1973 Nov; 49(9):557-9. PubMed ID: 4600926
    [No Abstract]   [Full Text] [Related]  

  • 6. Use of bromazepam in obsessional, phobic and related states.
    Burrell RH; Culpan RH; Newton KJ; Ogg GJ; Short JH
    Curr Med Res Opin; 1974; 2(7):430-6. PubMed ID: 4156004
    [No Abstract]   [Full Text] [Related]  

  • 7. [Results of clinical trial of Ro-4-6270 in depressive-anxiety states].
    Ardito R; Paterni F
    Riv Neurobiol; 1967; 13(1):3-10. PubMed ID: 5602736
    [No Abstract]   [Full Text] [Related]  

  • 8. Monoamine oxidase inhibitors in obsessive-compulsive disorder.
    Jenike MA; Surman OS; Cassem NH; Zusky P; Anderson WH
    J Clin Psychiatry; 1983 Apr; 44(4):131-2. PubMed ID: 6833198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of the phobic obsessive-compulsive patient with oxazepam, an improved benzodiazepine compound.
    Orvin GH
    Psychosomatics; 1967; 8(5):278-80. PubMed ID: 4862919
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical experience with Ro 5-3350 (bromazepam).
    Draper R
    J Int Med Res; 1975; 3(3):214-22. PubMed ID: 162678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clomipramine in phobic and obsessional states: preliminary report.
    Silva FR; Wijewickrama HS
    N Z Med J; 1976 Jul; 84(567):4-6. PubMed ID: 1067503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical trial of a new drug, analog of chlordiazepoxide, for treatment of anxiety and tension.
    Gilbert MM
    Int J Neuropsychiatry; 1965 Dec; 1(6):556-8. PubMed ID: 5886535
    [No Abstract]   [Full Text] [Related]  

  • 13. [A new benzodiazepine screened in a parallel double-blind test].
    Lens F
    Acta Psychiatr Belg; 1974 May; 74(3):327-37. PubMed ID: 4156150
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of 7-bromo-5-(2-pyridyl)-3H-1, 4-benzodiazepine-2(1H)-one, bromazepam (Ro 5-3350), a new minor tranquilizer, on psychoneurosis with special reference to the obsessive-compulsive symptoms.
    Okuma T; Nakao T; Ogura C; Kishimoto A; Majima K
    Folia Psychiatr Neurol Jpn; 1971; 25(3):181-93. PubMed ID: 4948475
    [No Abstract]   [Full Text] [Related]  

  • 15. Clomipramine intravenous drip: treatment of obsessional and phobic anxiety states.
    Marshall WK
    Nurs Times; 1972 Nov; 68(46):1448-9. PubMed ID: 4635061
    [No Abstract]   [Full Text] [Related]  

  • 16. [Use of phenazepam in the treatment of neurotic conditions].
    Dubnitskaia EB; Basov AM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1978; 78(9):1382-6. PubMed ID: 30245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical experience with a new minor tranquilizer, CS-370].
    Takaishi N; Minami S; Hino K; Kaneko J
    No To Shinkei; 1972 Feb; 24(2):237-42. PubMed ID: 5066941
    [No Abstract]   [Full Text] [Related]  

  • 18. [Chlorimipramine as the major treatment of depressive states (103 cases treated with intravenous perfusion)].
    Maillet-Jurquet A; Rance AM; Tollinchi G; Rance A; Roger J
    Encephale; 1970; 59(2):180-8. PubMed ID: 5458712
    [No Abstract]   [Full Text] [Related]  

  • 19. Doxepin in the treatment of hospitalized and ambulatory psychoneurotic patients.
    Sterlin C; Ban TA; Lehmann HE; Jarrold L
    Int J Clin Pharmacol; 1972 Aug; 6(3):256-9. PubMed ID: 4648468
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical experience with lorazepam in the treatment of neurotic patients.
    De Buck R
    Curr Med Res Opin; 1973; 1(5):291-5. PubMed ID: 4589715
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.